Molecular and Genetic Medicine

Rosa VDL

Publications

• Case Report
  Cutaneous Toxicity from Epidermal Growth Factor Receptor Inhibitors: A Report of Two Cases
  Author(s): Rosa VDL, Marota EP, Da Mata JC, Sampaio MM and De Oliveira JRRosa VDL, Marota EP, Da Mata JC, Sampaio MM and De Oliveira JR
  
  Epidermal growth factor inhibitors are currently an essential treatment for many advance-stage epithelial cancers as colorectal and lung cancer. Although they are safe, these agents often present cutaneous adverse events that can cause dosage reduction, interruption of treatment and psychosocial discomfort. We report two cases of cutaneous toxicity in patients with solid tumors using different epidermal growth factor inhibitors. .. Read More»
  DOI: 10.4172/1747-0862.1000294

  Abstract PDF